Safe glycemic management during closed-loop treatment of type 1 diabetes: The role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia

Medicine & Life Sciences

• Glucagon 66%
• Hyperglycemia 58%
• Type 1 Diabetes Mellitus 57%
• Insulin Resistance 52%
• Hypoglycemia 37%
• Outpatients 28%
• Insulin 26%
• Biofouling 20%
• Glucose 16%
• Politics 15%
• Safety 14%
• Self-Management 13%
• Calibration 13%
• Psychological Distress 12%
• Social Adjustment 12%
• Therapeutics 10%
• Life Style 10%
• Adrenal Cortex Hormones 10%
• Inpatients 10%
• Hormones 9%
• Research Personnel 8%
• Exercise 8%

Engineering & Materials Science

• Insulin 85%
• Medical problems 70%
• Compensation and Redress 48%
• Sensors 32%
• Closed loop systems 29%
• Closed loop control systems 20%
• Adrenal Cortex Hormones 15%
• Amperometric sensors 13%
• Glucose sensors 12%
• Biofouling 11%
• Hormones 11%
• Glucose 9%
• Redundancy 6%
• Derivatives 6%
• Calibration 6%
• Testing 4%

Chemical Compounds

• Glycemic 100%
• Glucagon 86%
• Insulin Derivative 65%
• Safety 15%
• Glucose 13%
• Adrenal Cortex Hormone 11%
• Hormone 9%
• Disorder 7%
• Dose 6%